16 / 20
Page 42
Notes:
Microbiology: Current Research 2017 | Volume 1, Issue 2
allied
academies
Joint Conference
GLOBAL APPLIED MICROBIOLOGY CONFERENCE
MICROBIAL & BIOCHEMICAL RESEARCH AND TECHNOLOGIES
&
October 18-19, 2017
Toronto, Canada
International Congress on
T
he last decade has seen an explosion of new technology
and diagnostics in clinical microbiology. So, where are all
the tests for infectious diseases at the point of care? Can we
find the Holy Grail of diagnostics or does something else define
its success? What does the US point of care quest have in
commonwith the global healthcare community and vice-versa?
This presentation looks at near patient testing for infectious
diseases as it evolves in the US, both because of and despite the
influence of global medicine and ex-US markets. A view from
both ends of the telescope is presented to provide up-close
and wide-angle perspectives. To that end, clinical case-based
examples introduce and illustrate a system-based interrogation
of considerations: themythology of laboratory decentralization,
want versus need, technology versus innovation, barriers to
implementation, biosafety, governance, quality management,
and outcome analysis.
Speaker Biography
Nancy S Miller is a board-certified Pathologist and a Clinical Microbiologist-Laboratory
Director with more than 15 years’ experience in infectious disease diagnostics and
patient care. She has earned an MD with distinction in research from SUNY-Stony
Brook and completed her residency in Anatomic and Clinical Pathology and fellowship
training in Medical Microbiology, all at the Johns Hopkins Medical Institutions.
Currently, she is the Medical Director of Clinical Microbiology and Molecular
Diagnostics at Boston Medical Center, where she is immersed in the daily challenges of
diagnostic microbiology and process improvement. Also, she is an Associate Professor
in the Department of Pathology and Laboratory Medicine at Boston University
School of Medicine. These responsibilities complement her translational research in
innovative and improved diagnostics for infectious diseases, method comparisons, and
outcome studies. Recent work includes PI-initiated commercial grants and academic
collaborations with Boston University colleagues including NIH-supported projects.
e:
nancy.miller@bmc.orgNancy S Miller
Boston Medical Center, USA
A point of view about point of care testing for diagnostic microbiology in the US:
What we have, what we need, what is on the way?